Literature DB >> 26303285

Abuse of New Psychoactive Substances: Threats and Solutions.

Michael H Baumann1, Nora D Volkow2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26303285      PMCID： PMC4707839          DOI： 10.1038/npp.2015.260

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  4 in total

1.  Synthetic Cannabinoid-Related Illnesses and Deaths.

Authors:  Jordan Trecki; Roy R Gerona; Michael D Schwartz
Journal:  N Engl J Med       Date:  2015-07-09       Impact factor: 91.245

Review 2.  Baths salts, spice, and related designer drugs: the science behind the headlines.

Authors:  Michael H Baumann; Ernesto Solis; Lucas R Watterson; Julie A Marusich; William E Fantegrossi; Jenny L Wiley
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

3.  The new drug phenomenon.

Authors:  Simon D Brandt; Leslie A King; Michael Evans-Brown
Journal:  Drug Test Anal       Date:  2014-07-03       Impact factor: 3.345

4.  Effects of Schedule I drug laws on neuroscience research and treatment innovation.

Authors:  David J Nutt; Leslie A King; David E Nichols
Journal:  Nat Rev Neurosci       Date:  2013-06-12       Impact factor: 34.870
  4 in total
  19 in total

Review 1.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

2.  The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.

Authors:  Simon D Brandt; Hailey M Walters; John S Partilla; Bruce E Blough; Pierce V Kavanagh; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2020-09-01       Impact factor: 4.530

Review 3.  Utility of Nonhuman Primates in Substance Use Disorders Research.

Authors:  Matthew L Banks; Paul W Czoty; Sidney S Negus
Journal:  ILAR J       Date:  2017-12-01

4.  Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release.

Authors:  Amy J Eshleman; Katherine M Wolfrum; John F Reed; Sunyoung O Kim; Tracy Swanson; Robert A Johnson; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2016-10-31       Impact factor: 4.030

Review 5.  Understanding the UK Psychoactive Substances Act.

Authors:  Raymond G Hill
Journal:  Br J Clin Pharmacol       Date:  2020-01-03       Impact factor: 4.335

6.  2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors.

Authors:  Adam L Halberstadt; Simon D Brandt; Donna Walther; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2019-03-23       Impact factor: 4.530

Review 7.  Overview of Monoamine Transporters.

Authors:  Shaili Aggarwal; Ole V Mortensen
Journal:  Curr Protoc Pharmacol       Date:  2017-12-20

8.  Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro.

Authors:  Marco Niello; Daniela Cintulová; Philip Raithmayr; Marion Holy; Kathrin Jäntsch; Claire Colas; Gerhard F Ecker; Harald H Sitte; Marko D Mihovilovic
Journal:  Front Pharmacol       Date:  2021-04-09       Impact factor: 5.988

9.  When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use.

Authors:  Kirsten E Smith; Jeffery M Rogers; Justin C Strickland; David H Epstein
Journal:  Am J Drug Alcohol Abuse       Date:  2021-04-28       Impact factor: 3.912

Review 10.  DARK Classics in Chemical Neuroscience: Aminorex Analogues.

Authors:  Julian Maier; Felix P Mayer; Simon D Brandt; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2018-10-05       Impact factor: 5.780
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.